Used as a key intermediate in the synthesis of selective kinase inhibitors, particularly in pharmaceutical research targeting cancer therapies. Its structure enables effective binding to specific enzyme active sites, making it valuable in developing drugs that modulate signaling pathways involved in tumor growth. Commonly employed in Suzuki and Negishi coupling reactions to construct complex biaryl systems found in bioactive molecules. Also utilized in the preparation of pyrazole-based compounds with potential antitumor and anti-inflammatory activities. Its trityl-protected form enhances stability during multi-step syntheses, allowing for high-yield transformations in medicinal chemistry campaigns.